Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Catechol-O-methyltransferase Val(108/158)Met polymorphism affects fronto-limbic connectivity during emotional processing in bipolar disorder.
|
28049082 |
2017 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
A gene coexpression network was developed based on a mutual information approach including four candidate genes (NRG1, DISC1, BDNF and COMT) along with other coexpressing genes in unipolar disorder, bipolar disorder and schizophrenia.
|
22777684 |
2012 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A significant association between bipolar disorder and COMT polymorphisms was found.
|
15211633 |
2004 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
A significant association between bipolar disorder and COMT polymorphisms was found.
|
15211633 |
2004 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Allele G from COMT SNPs rs4680 and rs165599 may represent reliable state-dependent predictors of global CD during manic and mixed episodes in BD.
|
22713126 |
2012 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder.
|
20122740 |
2010 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Associations with the COMT polymorphism were absent in relatives of patients with bipolar disorder and control participants.
|
19025226 |
2008 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Because dopaminergic disturbance is thought to be involved in the development of bipolar disorder (BPD), it seems essential to investigate dopamine-related genes like the catechol-O-methyltransferase (COMT) gene, which are involved in dopamine metabolism, and the methylenetetrahydrofolate reductase (MTHFR) gene, which may affect COMT methylation and COMT function.
|
25744938 |
2015 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Cognitive manic symptoms in bipolar disorder associated with polymorphisms in the DAOA and COMT genes.
|
23861766 |
2013 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Cognitive manic symptoms in bipolar disorder associated with polymorphisms in the DAOA and COMT genes.
|
23861766 |
2013 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Findings support the COMT Val158Met polymorphism conferring vulnerability for different clinical phenotypes in schizophrenia and bipolar disorder.
|
18571901 |
2008 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Findings support the COMT Val158Met polymorphism conferring vulnerability for different clinical phenotypes in schizophrenia and bipolar disorder.
|
18571901 |
2008 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation at the catechol-O-methyltransferase (COMT) gene has been significantly associated with risk for various neuropsychiatric conditions such as schizophrenia, panic disorder, bipolar disorders, anorexia nervosa and others.
|
18574484 |
2010 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Genotyping for COMT polymorphisms was carried out by DNA direct sequencing in 112 patients (54 MDD and 58 BD) and 58 healthy subjects.
|
25766270 |
2015 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Here, we report the investigation of the differential activity of membrane-bound catechol-O-methyltransferase (MB-COMT) due to altered promoter methylation and the nature of the contribution of COMT Val158Met polymorphism as risk factors for schizophrenia and bipolar disorder by analyzing 115 post-mortem brain samples from the frontal lobe.
|
16984965 |
2006 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we partially replicated our previous findings confirming a possible influence of COMT variants in MD and BD, particularly in early onset subjects, though not with the same risk genotypes.
|
21600957 |
2011 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
In this paper, we review extant studies involving neurocognitive-genetic and neuroimaging-genetic perspectives and particularly related to catechol-O-methyltransferase (COMT), brain-derived neurotrophic factor (BDNF) and neuregulin-1 (NRG1) genes in SZ and BD.
|
21688113 |
2011 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
In this study, we first investigate the possible association between the Val/Met polymorphism in COMT and bipolar disorder in the Han population, which has never been done before.
|
19578924 |
2009 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.
|
16542735 |
2006 |
Bipolar Disorder
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
It has been suggested that a common functional genetic polymorphism in the COMT gene, which results in 3 to 4-fold difference in COMT enzyme activity, may contribute to the etiology of mental disorders such as bipolar disorder and alcoholism.
|
10395222 |
1999 |
Bipolar Disorder
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder.
|
9264133 |
1997 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Monoaminergic dysfunction has been implicated in the pathogenesis of BP, it may be important to investigate genes such as the catechol-O-methyltransferase (COMT), involved in monoamine metabolism and brain-derived neurotrophic factor (BDNF) genes, modulating the monoamine system.
|
23026378 |
2013 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
BEFREE |
Moreover, COMT was risk factor for onset of both major depression and bipolar disorder, in conjunction with adversities.
|
16756688 |
2007 |
Bipolar Disorder
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Nevertheless, the specific relevance of COMT enzymatic activity in the pathophysiology of BD and schizophrenia dimensions remains elusive.
|
27458023 |
2017 |